“…The earlier cytology and noncytology literature (ie, that published prior to 2015) includes discussions regarding the cost‐effectiveness of ROSE in fine‐needle aspiration (FNA) using mathematical models, the use of ROSE by endosonographers in diagnosing pancreatic solid lesions, the diagnostic accuracy of TBNA without ROSE, the role of the pulmonologist in ROSE, ROSE used essentially as a frozen section, comparison of ROSE by lesion size, and the comparison of liquid‐based and smear‐based cytology with and without ROSE . Although the majority of the literature is concerned with thoracic pathology, lesions of the thyroid, pancreas, breast, and head and neck as well as intra‐abdominal and submucosal lesions also are represented.…”